Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05782907
What this trial is testing

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
AbbVie 122
Post-approval studies (Phase 4)Study completedNCT05029921
What this trial is testing

Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 182
Post-approval studies (Phase 4)WithdrawnNCT02760615
What this trial is testing

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda
Large-scale testing (Phase 3)Ended earlyNCT03467958
What this trial is testing

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Celgene 854
Testing effectiveness (Phase 2)Ended earlyNCT04130919
What this trial is testing

Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 19
Large-scale testing (Phase 3)Study completedNCT03945019
What this trial is testing

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

Who this might be right for
Crohn's Disease
Celltrion 396
Not applicableEnded earlyNCT00936585
What this trial is testing

NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease

Who this might be right for
ColitisCrohn's DiseaseInflammatory Bowel Disease
National Institutes of Health Clinical Center (CC) 2
Testing effectiveness (Phase 2)Study completedNCT02840721
What this trial is testing

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

Who this might be right for
Colitis, Ulcerative
Telavant, Inc. 50
Large-scale testing (Phase 3)UnknownNCT04919252
What this trial is testing

Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease

Who this might be right for
Crohn's Disease and Ulcerative Colitis
Yonsei University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06233461
What this trial is testing

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 268
Testing effectiveness (Phase 2)Looking for participantsNCT07229950
What this trial is testing

Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

Who this might be right for
Adult Patients With Moderately to Severely Active Ulcerative Colitis
Shandong Suncadia Medicine Co., Ltd. 48
Not applicableEnded earlyNCT03209232
What this trial is testing

Infliximab Accelerated Induction in Moderate to Severe Pediatric UC

Who this might be right for
Ulcerative Colitis
Schneider Children's Medical Center, Israel 10
Large-scale testing (Phase 3)Study completedNCT01470612
What this trial is testing

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 944
Testing effectiveness (Phase 2)Looking for participantsNCT07078994
What this trial is testing

Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease (CD)
Biocad 204
Early research (Phase 1)Study completedNCT04254783
What this trial is testing

Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative Colitis (UC)Crohn's Disease
AbbVie 20
Not applicableStudy completedNCT02846961
What this trial is testing

Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseaseUlcerative ColitisCrohn's Disease
Kyungpook National University Hospital 280
Testing effectiveness (Phase 2)Ended earlyNCT01545050
What this trial is testing

Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
CSL Behring 72
Large-scale testing (Phase 3)Looking for participantsNCT07184996
What this trial is testing

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sanofi 980
Large-scale testing (Phase 3)WithdrawnNCT04469062
What this trial is testing

Mirikizumab (LY3074828) in Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company
Post-approval studies (Phase 4)Study completedNCT02148718
What this trial is testing

Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease

Who this might be right for
Moderate to Severe Crohn's Disease
AbbVie 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation